pioglitazone has been researched along with Neointima in 3 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Neointima: The new and thickened layer of scar tissue that forms on a PROSTHESIS, or as a result of vessel injury especially following ANGIOPLASTY or stent placement.
| Excerpt | Relevance | Reference |
|---|---|---|
| "PIO attenuates injury-induced neointima formation, in part, through the activation of AMPK." | 5.46 | Pioglitazone Attenuates Injury-Induced Neointima Formation in Mouse Femoral Artery Partially through the Activation of AMP-Activated Protein Kinase. ( Fairaq, A; Osman, I; Segar, L, 2017) |
| "PIO attenuates injury-induced neointima formation, in part, through the activation of AMPK." | 1.46 | Pioglitazone Attenuates Injury-Induced Neointima Formation in Mouse Femoral Artery Partially through the Activation of AMP-Activated Protein Kinase. ( Fairaq, A; Osman, I; Segar, L, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Osman, I | 1 |
| Fairaq, A | 1 |
| Segar, L | 1 |
| Hong, SJ | 1 |
| Choi, SC | 1 |
| Cho, JY | 1 |
| Joo, HJ | 1 |
| Park, JH | 1 |
| Yu, CW | 1 |
| Lim, DS | 1 |
| Kubota, T | 1 |
| Kubota, N | 1 |
| Sato, H | 1 |
| Inoue, M | 1 |
| Kumagai, H | 1 |
| Iwamura, T | 1 |
| Takamoto, I | 1 |
| Kobayashi, T | 1 |
| Moroi, M | 1 |
| Terauchi, Y | 1 |
| Tobe, K | 1 |
| Ueki, K | 1 |
| Kadowaki, T | 1 |
1 trial available for pioglitazone and Neointima
| Article | Year |
|---|---|
Pioglitazone increases circulating microRNA-24 with decrease in coronary neointimal hyperplasia in type 2 diabetic patients- optical coherence tomography analysis.
Topics: Aged; Coronary Vessels; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Hyperplasi | 2015 |
2 other studies available for pioglitazone and Neointima
| Article | Year |
|---|---|
Pioglitazone Attenuates Injury-Induced Neointima Formation in Mouse Femoral Artery Partially through the Activation of AMP-Activated Protein Kinase.
Topics: Administration, Oral; AMP-Activated Protein Kinases; Animals; Cell Proliferation; Disease Models, An | 2017 |
Pioglitazone Ameliorates Smooth Muscle Cell Proliferation in Cuff-Induced Neointimal Formation by Both Adiponectin-Dependent and -Independent Pathways.
Topics: Adiponectin; Animals; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Humans; Mice; Mic | 2016 |